PB
Palimpsest Bio Corp.
SEC filingBiotechnology · Las Vegas, NV
Amount raised$172Ksold at filing
Total offering$1M$828K still open
Investors in the raise4count reported to the SEC
FiledOct 30, 2026first sale Jun 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew Davin KorpelaExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.